KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ:307750)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,125.00
-65.00 (-1.55%)
At close: Aug 14, 2025, 3:30 PM KST

KUKJEON PHARMACEUTICAL Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
206,110172,478306,192324,839537,308
Market Cap Growth
-49.17%-43.67%-5.74%-39.54%-
Enterprise Value
225,234178,557319,290284,635-
Last Close Price
4125.003515.006222.176590.2610900.81
PE Ratio
140.5399.3463.4736.30133.06
PS Ratio
1.521.262.513.136.30
PB Ratio
2.051.773.143.526.46
P/TBV Ratio
2.071.803.223.606.50
P/FCF Ratio
68.0079.52---
P/OCF Ratio
27.8217.19--176.63
EV/Sales Ratio
1.661.312.622.75-
EV/EBITDA Ratio
55.9132.6333.1157.72-
EV/EBIT Ratio
-486.9249.0581.60-
EV/FCF Ratio
74.3182.32---
Debt / Equity Ratio
0.570.670.810.640.09
Debt / EBITDA Ratio
13.9711.948.1712.031.09
Debt / FCF Ratio
19.0930.11---
Asset Turnover
0.620.620.580.68-
Inventory Turnover
4.384.224.054.62-
Quick Ratio
0.900.850.941.672.72
Current Ratio
1.251.191.242.023.52
Return on Equity (ROE)
0.32%0.55%4.95%10.12%-
Return on Assets (ROA)
-0.32%0.10%1.93%1.44%-
Return on Capital (ROIC)
-0.42%0.14%2.48%1.80%-
Return on Capital Employed (ROCE)
-0.30%5.20%2.80%7.20%
Earnings Yield
0.70%1.01%1.58%2.76%0.75%
FCF Yield
1.47%1.26%-14.46%-9.02%-1.37%
Dividend Yield
0.24%0.28%---
Payout Ratio
34.03%28.26%-5.48%-
Buyback Yield / Dilution
-0.10%-4.23%-16.16%-
Total Shareholder Return
0.14%0.28%4.23%-16.16%-
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.